CT sues McKesson for allegedly inflating drug prices

The Connecticut attorney general's office is suing pharmaceutical distributor McKesson Corp., contending that it's been illegally inflating the average wholesale price of more than 400 brand-name drugs, ultimately generating millions of dollars in unnecessary costs. The suit contends that McKesson conspired with drug-price publisher First DataBank to raise average wholesale prices (the amount pharmacies and providers charge consumers and insurers for medications) from 20 to 25 percent on many drugs. At the same time, it kept the prices pharmacies and providers paid for drugs at the same level. Under these circumstances, the higher retail prices gave the pharmacies and providers a much bigger profit margin, giving them a strong incentive to work with McKesson, the state says. The suit accuses McKesson of violating Connecticut's consumer-protection laws and the federal racketeering act.

To learn more about this story:
- read this Modern Healthcare piece (reg. req.)

Related Article:
PBM study critical of role played by benefits managers

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.